Sigachi Industries has informed that the company’s one of India’s leading players in pharmaceutical excipients, APIs, and specialty ingredients, is set to strengthen its scientific and technical capabilities with the commencement of operations at its newly established R&D Center in Hyderabad. Positioned as a critical pillar of the company’s innovation strategy, this R&D Center will drive end-to-end API development—from lab-scale innovation to commercialization and global regulatory filings. A press release to this extent is enclosed.
The above information is a part of company’s filings submitted to BSE.
